Phase I trial of IT 235 for cancer

Trial Profile

Phase I trial of IT 235 for cancer

Not yet recruiting
Phase of Trial: Phase I

Latest Information Update: 19 Jun 2013

At a glance

  • Drugs IT 235 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 19 Jun 2013 Planned initiation date changed to 1 Dec 2013, based on information in an Intezyne media release.
    • 08 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top